Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| GLOBAL GEOPH | GGS | 7.79% |
| STAAR SURGIC | STAA | 6.23% |
| KAPSTONE PAP | KS | 6.14% |
| HORNBECK OFF | HOS | 5.99% |
| ANIKA THERAP | ANIK | 5.55% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Central Garden & Pet Company (CENT - Analyst Report), the leading producer of garden and pet supplies products in the U.S., recently announced a new $100.0 million share buyback program.
Share buybacks reflects the company’s sound financial position and well-defined future prospects. The signs of recovery in the economy have made share buybacks and dividend increases a common factor among companies sitting on extra cash. These strategies enhance shareholders’ return and boost the market value of the stock.
The newly announced program would take place through open market or private transactions.
Central Garden’s diversified portfolio of brands has helped it to develop a healthy commercial relationship with giant retailers, such as Wal-Mart Stores Inc. (WMT - Analyst Report) and The Home Depot Inc. (HD - Analyst Report). This provides a significant upside potential to the company.
The company recently posted better-than-expected second-quarter 2011 results. The quarterly earnings of $0.54 per share beat the Zacks Consensus Estimate of $0.49 and rose 10.2% from the prior-year quarter. Total net sales climbed 10%, surpassing the Zacks Consensus Revenue Estimate of $457.0 million.
The company’s effective inventory management is helping it to optimize merchandise levels in accordance with the sales trends. Further, Central Garden & Pet is implementing an enterprise-wide information technology platform, which is expected to improve working capital management.
The company has been focusing on improving its gross and operating margins. To achieve its goal, Central Garden & Pet has tried every means to improve its sales, consolidate manufacturing facilities and logistics centers. Further, the company made prudent capital investments while focusing on improving manufacturing efficiencies.
However, the discretionary spending environment continues to remain sluggish amid high unemployment levels and tight credit markets. This is especially a matter of concern for the company as a significant portion of its product portfolio consists of premium offerings.
Currently, wemaintain a long-term ‘Outperform’ recommendation on the stock. Moreover, Central Garden & Pet holds a Zacks #1 Rank, which translates into a short-term ‘Strong Buy’ rating.
Get the full Analyst Report on WMT - FREE
Get the full Analyst Report on HD - FREE
Get the full Analyst Report on CENT - FREE